Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Gastrointestinal" returned 7 results:


A Phase Ib Study of Fractionated 90Y-hPAM4 with or without Gemcitabine in Patients with Metastatic Pancreatic Cancer who Received at Least Two Prior Treatments
Principal Investigator(s): Max W. Sung

CALGB 80803: Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer
Principal Investigator(s): Celina Ang

Phase I Trial of Adenoviral Vector Delivery of the Human Interleukin-12 cDNA by Intratumoral Injection in Patients with Metastatic Colorectal Cancer to the Liver (Colon)
Principal Investigator(s): Max W. Sung

A Phase 1b/2 Multicenter, International, Randomized, Double Blind, placebo-controlled Study of Gemcitabine Combined with PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Compared to Gemcitabine Combined with Placebo in Patients with Stage IV Previously Untreated Pancreatic Cancer
Principal Investigator(s): Randall Holcombe

A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine
Principal Investigator(s): Randall Holcombe

A phase III study of chemotherapy and chemoradiotherapy with or without hyperacute- pancreatic vaccine in subjects with surgically resected pancreatic cancer
Principal Investigator(s): Daniel M. Labow

A Phase I/II Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
Principal Investigator(s): Randall Holcombe